FDA Adverse Event Injury Summary report: N

AMPLATZER VASCULAR PLUG

MDR report key: 17827547 · Received September 27, 2023

Report

Report Number
2135147-2023-04208
Event Type
Injury
Date Received
September 27, 2023
Report Date
October 10, 2023
Manufacturer
ABBOTT MEDICAL
Product Code
KRD
PMA / PMN Number
K031810
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SUMMARIZED PATIENT OUTCOMES/COMPLICATIONS OF AMPLATZER VASCULAR PLUG WERE REPORTED IN A RESEARCH ARTICLE IN A SUBJECT POPULATION WITH LEFT SIDED PELVIC PAIN. IT WAS REPORTED THAT POST PROCEDURE SURGICAL INTERVENTION AND HOSPITALIZATION WAS REQUIRED. A MORE COMPREHENSIVE ASSESSMENT COULD NOT BE PERFORMED AS THE EVENT WAS NON-CONTEMPORANEOUSLY REPORTED THROUGH A LITERATURE REVIEW AND NO DEVICE OR INDIVIDUAL PATIENT INFORMATION WAS RECEIVED FOR ANALYSIS.

Additional Manufacturer Narrative · 0

INVESTIGATION IS NOT YET COMPLETE. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.

Description of Event or Problem · 0

THE ARTICLE, "NUTCRACKER", WAS REVIEWED. THE ARTICLE PRESENTED A CASE STUDY OF A 53 YEAR OLD FEMALE PATIENT WITH AGGRAVATED LEFT SIDED PELVIC PAIN. IT WAS REPORTED ON AN UNKNOWN DATE, A DECISION WAS MADE TO IMPLANT AN UNKNOWN AMPLATZER VASCULAR PLUG TO EMBOLIZE THE LEFT OVARIAN VEIN WITH A CONCOMITANT 12X40MM NON-ABBOTT STENT IMPLANTED IN THE LEFT RENAL VEIN. PRE-PROCEDURALLY, IT WAS CONFIRMED THERE WAS LEFT RENAL VEIN STENOSIS, LEFT OVARIAN VEINS DILATATION, AND PELVIC VARICOSE VEINS. IT WAS LATER REPORTED 6 MONTHS LATER ON AN UNKNOWN DATE, RECANALIZATION OF THE LEFT OVARIAN VEIN WAS CAUSED BY COLLATERAL BLOOD VESSEL DEVELOPMENT. A DECISION WAS MADE TO IMPLANT A NON-ABBOTT PLUG IN THE RIGHT OVARIAN VEIN WITH CONCOMITANT SECONDARY STENT IMPLANT IN THE INFERIOR VENA CAVA OVERLAPPING THE STENT IN THE LEFT RENAL VEIN. THE PATIENT WAS DISCHARGED ON ANTICOAGULATION THERAPY. NO RECURRENCE OF PELVIC CONGESTION SYNDROME WAS CONFIRMED AND IT WAS CONFIRMED 6 MONTHS FOLLOWING THE SECOND PROCEDURE, THERE STENT IMPLANTS REMAINED IN PLACE, OCCLUSION OF THE BILATERAL OVARIN VEINS, AND WITHDRAWAL OF PELVIC VARICOSE. [THE PRIMARY AUTHOR OF THE ARTICLE WAS TAKIZAWA, SHIMADA GENERAL HOSPITAL, 288-0053 CHIBA, CHOSHI, HIGASHICHO, 5-3, JAPAN].

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
724377 AMPLATZER VASCULAR PLUG DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION KRD ABBOTT MEDICAL

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention| H